CTK8A3536

CAS No. 926228-58-2

CTK8A3536( (2-MORPHOLIN-4-YL-4-PHENYL-1,3-THIAZOL-5-YL)METHANOL )

Catalog No. M22238 CAS No. 926228-58-2

CTK8A3536 is an inhibitor of Androgen receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 177 Get Quote
5MG 268 Get Quote
10MG 408 Get Quote
25MG 672 Get Quote
50MG 945 Get Quote
100MG 1278 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CTK8A3536
  • Note
    Research use only, not for human use.
  • Brief Description
    CTK8A3536 is an inhibitor of Androgen receptor.
  • Description
    CTK8A3536 is an inhibitor of Androgen receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (2-MORPHOLIN-4-YL-4-PHENYL-1,3-THIAZOL-5-YL)METHANOL
  • Pathway
    Endocrinology/Hormones
  • Target
    Androgen Receptor (AR)
  • Recptor
    Androgen receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    926228-58-2
  • Formula Weight
    276.35
  • Molecular Formula
    C14H16N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCc1[s]c(nc1c2ccccc2)N3CCOCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AZD3514

    AZD3514 is a potent and oral androgen receptor downregulator with Ki of 2.2 μM and has ability of reducing AR protein expression.Phase 1.

  • Dimethylcurcumin

    Dimethylcurcumin (ASC-J9) is an androgen receptor degradation enhancer. It effectively suppresses castration-resistant prostate cancer cell proliferation and invasion.Dimethylcurcumin is able to degrade fAR and AR3 in a dose-dependent manner in various human PCa cells. Dimethylcurcumin can also effectively suppress AR-targeted genes in CWR22Rv1-fARKD cells.

  • N-desmethyl Enzaluta...

    Amajor metabolite of Enzalutamide (MDV3100) which is an androgen-receptor (AR) antagonist for treatment of prostate cancer.